Loading…
Loading…
EQUITY / NASDAQ · XNMS
Actuate Therapeutics, Inc.
01 / RESEARCH
8 financial reports are available for research.
Start research ↗0.7797 USD
Observed: 09/30/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
09/30/2026 · 0.7797 USD · Volume 409,627
252 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Cash and cash equivalents | 4,425,841 USD | — | — |
| Net income | -4,866,635 USD | -5,949,405 USD | — |
| Operating profit | -4,906,588 USD | -5,968,877 USD | — |
| Total assets | 5,199,339 USD | — | — |
| Total equity | 989,152 USD | -2,653,704 USD | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD | 2025 / Year endConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 4,425,841 USD | — | — | — | 13,159,423 USD | 16,924,763 USD | — | — |
| Net incomeIncome statement | -4,866,635 USD | -10,492,384 USD | -5,625,749 USD | — | -22,227,852 USD | -5,407,470 USD | -17,673,899 USD | -5,949,405 USD |
| Operating profitIncome statement | -4,906,588 USD | -10,612,544 USD | — | — | -22,495,312 USD | -5,472,378 USD | -17,806,839 USD | -5,968,877 USD |
| Total assetsBalance sheet | 5,199,339 USD | — | — | 14,035,910 USD | 14,035,910 USD | 17,713,934 USD | — | — |
| Total equityBalance sheet | 989,152 USD | — | 3,784,398 USD | 7,924,003 USD | 7,924,003 USD | 10,936,281 USD | — | -2,653,704 USD |
| Total liabilitiesBalance sheet | 4,210,187 USD | — | — | 6,111,907 USD | 6,111,907 USD | 6,777,653 USD | — | — |
| Financing cash flowCash flow statement | — | 688,868 USD | — | — | 23,724,054 USD | — | 23,753,351 USD | — |
| Operating cash flowCash flow statement | — | -9,422,450 USD | — | — | -19,206,253 USD | — | -15,470,210 USD | — |
| Report source | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 03/26/2026 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 08/14/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.